111, Inc. Sponsored ADR (NASDAQ:YI) Sees Large Growth in Short Interest

111, Inc. Sponsored ADR (NASDAQ:YIGet Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 1,517 shares, an increase of 51.7% from the December 15th total of 1,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 12,774 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 12,774 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 111 in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Read Our Latest Research Report on YI

111 Trading Down 0.7%

NASDAQ:YI opened at $5.72 on Friday. The stock’s 50-day moving average is $3.60 and its 200-day moving average is $5.15. 111 has a 1-year low of $2.48 and a 1-year high of $11.35. The stock has a market cap of $49.42 million, a P/E ratio of -6.81 and a beta of 0.51.

111 (NASDAQ:YIGet Free Report) last posted its earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The company had revenue of $421.49 million for the quarter.

111 Company Profile

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.